Disease Modifying in Neurodegenerative Disease Treatment An Interview with Alon Ben-Noon, CEO & Founder of NeuroSense Therapeutics

NeuroSense Therapeutics led by CEO and founder Alon Ben-Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted...